Arvin Capital Management LP Charles River Laboratories International, Inc. Transaction History
Arvin Capital Management LP
- $317 Billion
- Q2 2024
A detailed history of Arvin Capital Management LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Arvin Capital Management LP holds 67,838 shares of CRL stock, worth $14.5 Million. This represents 4.42% of its overall portfolio holdings.
Number of Shares
67,838
Previous 49,681
36.55%
Holding current value
$14.5 Million
Previous $13.5 Billion
4.11%
% of portfolio
4.42%
Previous 5.04%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
712Shares Held
51.6MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.31 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$447 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$409 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$377 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.9B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...